Related Experiment Video
Updated: Jun 7, 2026

08:29
Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
Published on: June 7, 2018
Trends on schizophrenia admissions during the deinstitutionalisation process in Spain (1980-2004).
Zuleika Saz-Parkinson1, A Medel, P Cediel-García
1Instituto de Salud Carlos III, Madrid, Spain. zuleika@isciii.es
Social Psychiatry and Psychiatric Epidemiology
|October 26, 2010
Summary
Spain
Area of Science:
- Psychiatry
- Health Services Research
- Public Health Policy
Background:
- Deinstitutionalization reform in Spain initiated post-1980.
- Aimed to reduce hospitalizations, length of stay, and psychiatric beds.
- Focused on enhancing community involvement for psychiatric patients.
Purpose of the Study:
- To review the impact of Spain's psychiatric reform on schizophrenia patient management.
- Analyzed trends from 1980 to 2004.
Main Methods:
- Longitudinal study (1980-2004).
- Examined hospital morbidity variables for schizophrenia patients.
Main Results:
- Hospital admission rates increased; emergency admissions nearly tripled.
- Point-prevalence of inpatient schizophrenia treatment decreased by 78%.
- Average length of stay reduced significantly from 148 to 35 days.
Conclusions:
- Psychiatric reform led to a substantial reduction in hospital capacity for schizophrenia patients.
- Significant decrease in point-prevalence highlights reform's impact.
- Further research needed on resource reallocation to community care and pharmacotherapy.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
